HIT Consultant September 29, 2023
Fred Pennic

What You Should Know:

Phenomix Sciences, a precision medicine biotechnology company that brings data-driven precision medicine to obesity treatment, announced it has been awarded the first patent related to its obesity phenotyping technology.

– The patent (No. 11,740,247, titled “Methods and Materials for Assessing and Treating Obesity”) covers methods for treating obesity by identifying phenotypes through obesity analyte signatures and administering interventions, such as medications based on that signature.

What is obesity phenotyping?

Phenotyping classifies your type of obesity based on specific biological mechanisms. Understanding which of the four phenotypes you have pinpoints what is driving your weight gain and limiting your ability to lose weight. Using weight-loss solutions specific to your phenotype and genetic makeup...

Today's Sponsors


Today's Sponsor


Topics: Biotechnology, Health System / Hospital, Pharma / Biotech, Provider
Biotech venture firms continue ‘recalibration’ in third quarter, Pitchbook report finds
Forbes names 30 under 30 in healthcare
Insilico Medicine Launches First-in-Human Trial for AI-Discovered IBD Drug
How to Choose the Right Distribution Partner
Listen: CRISPR history, biotech struggles, & a big week for deals

Share This Article